Highly regarded healthcare regulatory attorney Dr. Jur Strobos has joined Baker McKenzie's North America Intellectual Property Practice as a partner, bringing more than 27 years of experience in a range of US Food and Drug Administration regulatory matters.

Based in Washington, DC, Dr. Strobos will also be a member of the Firm's North America Healthcare Industry Group. He has extensive experience providing legal and regulatory support, problem-solving and strategic analysis for US and international companies on compliance with tobacco, food and medical product regulations. Dr. Strobos, who is also a medical doctor, will work closely with Neil O'Flaherty, whose practice focuses on FDA regulatory issues related to medical devices.

"For clients in the healthcare industry, the need for FDA support is found at every stage in the lifecycle of the product," said Kevin O'Brien, Chair of the North America Intellectual Property Practice Group. "Jur is one of a select few lawyers with a medical background, and he is sought after for his advice on FDA regulations. His esteemed experience will immediately benefit our clients."

Added Jane Hobson, Chair of the Global Healthcare Industry Group, "Jur is a welcome addition to our global healthcare network. His experience ensures that Baker McKenzie’s pharmaceutical regulatory network can provide truly global coverage, with specialist knowledge of the US FDA and regulatory obligations within the world’s largest healthcare market.”

Known for his assistance on premarket review and approval by the FDA, Dr. Strobos has provided legal and regulatory consultations on a range of issues, such as clinical study design, special protocol assessments and IND/IDE preparation and filing. He has also shepherded multiple drugs and devices through FDA regulatory processes on behalf of clients.

"Jur's multifaceted background is truly unique, and his practice will perfectly complement our offerings in this area of FDA regulation," said Rick Hammett, Managing Partner of the Firm's North America region. "We are focused on expanding our capabilities across North America to better serve our clients, and Jur is another stand-out addition to our team."

Dr. Strobos joins the Firm from Olsson Frank Weeda Terman Matz PC. He temporarily left his practice at Olsson Frank in 2010 when the Bill and Melinda Gates Foundation funded his work on garnering international regulatory approval of drugs for HIV prophylaxis. He was subsequently funded by the Biomedical Advanced Research and Development Authority and the National Institutes of Health to develop medical countermeasures for potential terrorist attacks. He returned to his FDA practice in 2015.

Additionally, Dr. Strobos has published on a broad range of topics, including clinical trial design, pharmacovigilance, data analysis plans and safety evaluation. He also teaches a graduate course on drug development at the University of California Berkeley.

"Baker McKenzie offers the global infrastructure that will allow me to strengthen the FDA regulatory capabilities I offer my clients," Dr. Strobos said. "I am eager to lend my experience to pharmaceutical, healthcare and other companies as they navigate the FDA regulatory process."

Baker McKenzie's North America Intellectual Property Practice Group is composed of nearly 400 intellectual property lawyers in 40 countries, covering the full scope of IP services in more jurisdictions than any other firm. The practice received a Band 1 ranking by Chambers Global, and the 2015 Managing Intellectual Property awards named Baker McKenzie the "Global Law Firm of the Year."

The Firm's Global Healthcare Industry Group comprises more than 450 seasoned industry lawyers, serving healthcare companies across a variety of areas, including M&A and corporate transactions; tax; compliance and regulation; antitrust; disputes, anticorruption and intellectual property.

Dr. Strobos is the latest in a series of prominent lateral hires to join the Firm in Washington, DC. In recent months, tax practitioners Jennifer Molnar and Steven Schneider joined the office, as did litigator Mark Hamer and franchising lawyer Maggie Vaughan. Overall, Baker McKenzie has added 42 lateral partners in North America over the last two years, as it continues to strengthen its presence in key markets.

About Jur Strobos

Dr. Strobos received his BA from Johns Hopkins University and his MD from the University of Chicago, and he completed four years of surgical residency at New York University and West Virginia University.

While practicing medicine, Dr. Strobos obtained his JD from the University of Pennsylvania Law School. Following the completion of two clerkships with the US Court of Appeals, Dr. Strobos served as Director of Policy Research in the Office of the Commissioner at the FDA.


Explore Our Newsroom
See All News